Apr 10, 2024 07:00AM
Mar 12, 2024 08:00AM
Feb 13, 2024 07:00AM
Jan 4, 2024 04:01PM
Nov 20, 2023 07:31AM
Nov 20, 2023 07:30AM
Sep 6, 2023 06:01AM BiondVax Pharma (BVXV) Rebrands as Scinai Immunotherapeutics; Focuses on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics
Sep 6, 2023 06:00AM
Sep 6, 2023 06:00AM
Aug 11, 2023 09:01AM
Aug 11, 2023 09:00AM
Aug 1, 2023 04:02PM
Aug 1, 2023 04:01PM
Jun 5, 2023 07:00AM BiondVax signs exclusive license agreement for development and commercialization of a novel anti-IL-17 antibody for treatment of autoimmune and inflammatory diseases including psoriasis
May 15, 2023 04:46PM
May 15, 2023 04:45PM
Apr 17, 2023 04:26PM
Apr 17, 2023 04:25PM
Apr 17, 2023 04:25PM
Mar 16, 2023 01:10PM
Mar 16, 2023 01:10PM BiondVax to Present at BIO-Europe Spring
Feb 2, 2023 02:15PM
Feb 2, 2023 02:15PM
Jan 23, 2023 06:26AM
Jan 23, 2023 06:25AM
Jan 23, 2023 06:25AM
Jan 6, 2023 07:16AM
Jan 6, 2023 07:15AM BiondVax’s Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo Study
Jan 6, 2023 07:15AM
Jan 5, 2023 07:00AM
Jan 5, 2023 07:00AM
Dec 30, 2022 07:31AM
Dec 30, 2022 07:30AM
Dec 30, 2022 07:30AM
Dec 20, 2022 12:42PM BiondVax Announces Closing of $8 Million Underwritten Public Offering
Dec 20, 2022 12:42PM
Dec 16, 2022 08:49AM
Dec 16, 2022 08:48AM
Dec 16, 2022 08:48AM
Dec 12, 2022 07:14AM
Dec 12, 2022 07:06AM
Dec 6, 2022 07:30AM Professor Dr. Matthias Dobbelstein joins BiondVax’s Scientific Advisory Board
Dec 6, 2022 07:30AM
Nov 30, 2022 09:14AM
Nov 30, 2022 09:14AM
Nov 29, 2022 07:03AM
Nov 29, 2022 07:00AM
Nov 29, 2022 07:00AM
Nov 21, 2022 06:00AM BiondVax CEO to Present at the January 2023 Biotech Showcase in San Francisco
Nov 15, 2022 08:33AM

1,167,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All